- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Mark Friedberg on Achieving Professional Satisfaction in the Practice
In the last few years, there’s been a real surge in interest in professional satisfaction in healthcare, according to Mark Friedberg, MD, MPP, senior natural scientist and director of the Boston office at RAND Corporation.
In the last few years, there’s been a real surge in interest in professional satisfaction in healthcare, according to Mark Friedberg, MD, MPP, senior natural scientist and director of the Boston office at RAND Corporation.
Transcript
What larger initiatives are in place to address physician satisfaction and what do they hope to achieve?
In terms of large initiatives, in the last few years there’s been a real surge in interest in professional satisfaction in clinicians, physicians, and other types of clinicians as well. The American Medical Association, for example, has some efforts in place that are freely available to physician practices around the country. And these are general ideas on how to restructure in your practice to make it more durable basically.
There are also some what I call symptomatic treatments that have become popular like mindfulness training and other things that sort of like treat the symptom but not the cause. So like bringing tea or snacks around to people to make them feel appreciated in the practice. I do worry about that second category of popular approaches to professional satisfaction. The ones that are like mindfulness and the tea and you know appreciation letters. Those might be a cover up of underlying problems and you might be able to get a little bit of improvement in professional satisfaction without addressing any of the underlying issues and I do worry that that wouldn’t be a very good approach for people to take if on the other hand they could be addressing some underlying issues and getting a bump in professional satisfaction instead.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
